Sun Pharma reports consolidated net profit of Rs 1984 crore in Q4 Ruchika Sharma27 May 2023 8:00 AM GMT"Several of our businesses, including specialty, India and emerging markets have continued to progress well," Sun Pharma Managing Director Dilip...
USFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib Ruchika Sharma2 May 2023 9:16 AM GMTThe company said it would work closely with the FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next...
Concert Pharma Deuruxolitinib significantly improves scalp hair regrowth in Alopecia areata, reveals data Ruchika Sharma21 March 2023 7:45 AM GMTDeuruxolitinib is an investigational oral selective inhibitor of Janus kinases JAK1 and JAK2.
Sun Pharma concludes acquisition of Concert Pharma Ruchika Sharma7 March 2023 9:00 AM GMTAcquisition adds Deuruxolitinib for the treatment of alopecia areata, to Sun Pharma’s global dermatology portfolio
Sun Pharma to buy Concert Pharma for Rs 4678 crore Ruchika Sharma20 Jan 2023 6:56 AM GMT"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the first half of 2023," the...
